Device Trial Radar · NCT01716013
Safety and Efficacy Study of BondEase to Treat Traumatic Lacerations and Surgical Incisions
Last checked: Nov 19, 2026Latest source record: Jan 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
162
Actual
Start
Sep 2012
Primary completion
Jan 2014
Study completion Feb 2014
Sponsor
- Lead sponsor
- OptMed, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 29, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate that BondEase™ and conventional wound closure devices (CWCD) are the same in terms of cosmesis (appearance) of the repaired wound when these devices are used for closure of surgical and traumatic wounds . To demonstrate safety of BondEase™.
Conditions
- Traumatic Lacerations or Surgical Incisions
Interventions
BondEaseDevice
topical skin adhesive
CWCDProcedure
traditional closure methods of sutures, staples or adhesive strips
Primary outcomes
What the sponsor says the trial is designed to measure.
- 100% Wound Apposition at 10 DaysTime frame: 10 days
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Orlando Regional Medical Center
Orlando, Florida
Northwestern University
Chicago, Illinois
DC Cosmetics
Chevy Chase, Maryland
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.